Valuation: Astal Laboratories Limited

Market Cap 2.64B 27.94M 24.9M 22.78M 20.74M 39.1M 40.15M 274M 109M 1.4B 105M 103M 4.41B P/E 2025
9.45x
P/E 2026 8.37x
Enterprise Value 3.13B 33.15M 29.54M 27.02M 24.61M 46.38M 47.63M 325M 130M 1.66B 124M 122M 5.23B EV / Sales 2025
1.36x
EV / Sales 2026 1.31x
Free-Float
41%
Yield 2025 *
-
Yield 2026 -
1 day+3.11%
1 week-8.57%
Current month-2.29%
1 month-13.30%
3 months-27.34%
6 months-4.06%
Current year-30.58%
1 week 49.99
Extreme 49.99
64
1 month 49.99
Extreme 49.99
71.4
Current year 49.99
Extreme 49.99
91.9
1 year 49.99
Extreme 49.99
99.9
3 years 33.65
Extreme 33.65
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 15/07/2023
Director TitleAgeSince
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Director/Board Member - 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+3.11%-8.57%-37.78%+79.17% 27.1M
-3.76%-0.65%+47.41%+140.35% 1,263B
-1.45%-1.05%+46.41%+79.94% 665B
-2.24%-0.88%+32.97%+103.82% 521B
-1.06%-1.78%+48.37%+65.10% 387B
-2.27%+0.42%+74.12%+42.14% 371B
-0.10%+3.79%+32.16%+60.93% 310B
+0.13%+10.01%+12.08%+36.73% 293B
-3.80%-0.10%+43.90%+70.56% 259B
-3.96%+1.18%+36.70%+105.38% 216B
Average -1.54%+1.50%+33.64%+78.41% 428.54B
Weighted average by Cap. -2.33%+1.31%+43.63%+92.43%

Financials

2025 2026
Net sales 637M 6.74M 6M 5.49M 5M 9.42M 9.68M 65.96M 26.37M 337M 25.28M 24.74M 1.06B 2.49B 26.31M 23.45M 21.44M 19.53M 36.81M 37.81M 258M 103M 1.32B 98.76M 96.64M 4.16B
Net income 89.25M 944K 842K 770K 701K 1.32M 1.36M 9.25M 3.7M 47.27M 3.55M 3.47M 149M 147M 1.56M 1.39M 1.27M 1.16M 2.18M 2.24M 15.24M 6.09M 77.9M 5.84M 5.72M 246M
Net Debt 115M 1.22M 1.09M 995K 906K 1.71M 1.75M 11.96M 4.78M 61.11M 4.58M 4.48M 193M 492M 5.21M 4.64M 4.24M 3.86M 7.28M 7.48M 50.97M 20.38M 261M 19.54M 19.12M 822M
Projected Income Statement - Annual - Astal Laboratories Limited
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
22
Date Price Change Volume
05/11/26 ₹60.29 +3.11% 53,679
04/11/26 ₹58.47 +14.09% 53,855
03/11/26 ₹51.25 -4.58% 162,999
02/11/26 ₹53.71 -12.95% 116,752
30/10/26 ₹61.70 -2.17% 12,192
  1. Stock Market
  2. Stocks
  3. 512600 Stock